|
| |
Nasacort AQ®
See:
Nasacort
Drug Uses
Nasacort is FDA approved for the treatment
of the nasal symptoms of seasonal and year round allergies such as nasal
congestion, itchy runny nose, and sneezing. Nasacort Nasal Spray is an
unscented, thixotropic, water-based metered-dose pump spray formulation unit
containing a microcrystalline suspension of triamcinolone acetonide in an
aqueous medium.
How Taken
Nasacort Nasal Spray comes as a solution
to inhale through the nose. It usually is inhaled one to four times a day at
evenly spaced intervals. Before using triamcinolone, gently blow your nose to
clear your nasal passages. Avoid blowing your nose for 15 minutes after inhaling
the prescribed dose.
Warnings/Precautions
Before using this medication, tell your
doctor if you have a viral, bacterial, or fungal infection of any kind. The
absorption of this drug into the system can inhibit the body's ability to fight
off infections. You may not be able to use Nasacort Nasal Spray if you have an
infection. Nasacort Nasal Spray is in the FDA pregnancy C. This means that it is
not known whether Nasacort Nasal Spray will be harmful to an unborn baby. Do not
use this medication without first talking to your doctor if you are pregnant or
could become pregnant during treatment. It is not known whether Nasacort Nasal
Spray passes into breast milk. Do not use Nasacort Nasal Spray without first
talking to your doctor if you are breast-feeding a baby. Nasacort Nasal Spray is
not approved for children use younger than 12 years of age.
Missed Dose
If you miss a dose of Nasacort, use it as
soon as remembered; do not use if it is almost time for the next dose, instead,
skip the missed dose and resume your usual dosing schedule. Do not "double-up"
the dose to catch up.
Possible Side Effects
Nasacort may cause irritation, stinging,
burning, or dryness of the nasal passages. Sneezing, nosebleed, headache,
lightheadedness, loss of taste, throat irritation or nausea may also occur. If
these effects continue or become bothersome, inform your doctor. Unlikely but
report promptly: persistent nose or throat irritation/soreness, white patchy
areas. Very unlikely but report promptly: broken or damaged nasal membranes,
unusual weakness, weight loss, nausea/vomiting, fainting, dizziness, vision
changes. If you notice other effects not listed above, contact your doctor or
pharmacist.
Storage
Store at Controlled Room Temperature, 20
to 25°C (68 to 77°F) away from sunlight and moisture. Avoid freezing. Keep out
of reach of children.
Overdose
An overdose of this medication is not
likely to occur. If you do think that an overdose has occurred, call an
emergency room or poison control left for advice.
More Information
Avoid items or activities that are known
allergens to you. Clean areas where dust or pet fur may aggravate your
condition. Avoid exposing yourself to known sources of infection. Stay away from
people with chicken pox, measles, or any other type of infection. Your immune
system may not be strong enough to fight off an infection while using Nasacort.
Triamcinolone acetonide, USP, the active ingredient in Nasacort ®AQ Nasal Spray,
is a corticosteroid with a molecular weight of 434.51 and with the chemical
designation.
9-Fluoro-11ß,16 á
,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone
(C 24 H 31 FO 6 ).
Nasacort AQ Nasal Spray is an unscented, thixotropic, water-based metered-dose
pump spray formulation unit containing a microcrystalline suspension of
triamcinolone acetonide in an aqueous medium. Microcrystalline cellulose,
carboxymethylcellulose sodium, polysorbate 80, dextrose, benzalkonium chloride,
and edetate disodium are contained in this aqueous medium; hydrochloric acid or
sodium hydroxide may be added to adjust the pH to a target of 5.0 within a range
of 4.5 and 6.0.
Each actuation delivers 55 mcg triamcinolone acetonide from the nasal actuator
after an initial priming of 5 sprays.It will remain adequately primed for 2
weeks. If the product is not used for more than 2 weeks, then it can be
adequately reprimed with one spray. The contents of one 6.5 gram sample bottle
provide 30 actuations, and the contents of one 16.5 gram bottle provide 120
actuations. After either 30 actuations or 120 actuations,the amount of
triamcinolone acetonide delivered per actuation may not be consistent and the
unit should be discarded. Each 30 actuation sample bottle contains 3.575 mg of
triam-cinolone acetonide and each 120 actuation bottle contains 9.075 mg of
triamcinolone acetonide.
In the Information for Patient tear-off sheet, patients are provided with a
check-off form to track usage.
|
